{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:57:36Z","timestamp":1740142656426,"version":"3.37.3"},"reference-count":24,"publisher":"FapUNIFESP (SciELO)","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"DOI":"10.1590\/1806-9282.20200778","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T12:18:26Z","timestamp":1630066706000},"page":"385-389","source":"Crossref","is-referenced-by-count":2,"title":["The evaluation of patients with essential thrombocythemia in terms of risk of thrombosis"],"prefix":"10.1590","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6513-6211","authenticated-orcid":false,"given":"Cenk","family":"Sunu","sequence":"first","affiliation":[{"name":"Sakarya University Training and Research Hospital,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5522-8342","authenticated-orcid":false,"given":"Ahmet Kursad","family":"Gunes","sequence":"additional","affiliation":[{"name":"Ankara City Hospital,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4467-9724","authenticated-orcid":false,"given":"Gulten Korkmaz","family":"Akat","sequence":"additional","affiliation":[{"name":"Ankara City Hospital,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6944-9808","authenticated-orcid":false,"given":"Yasin","family":"Kalpakci","sequence":"additional","affiliation":[{"name":"Sakarya University Training and Research Hospital,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3173-7614","authenticated-orcid":false,"given":"Funda","family":"Ceran","sequence":"additional","affiliation":[{"name":"Ankara City Hospital,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0901-2043","authenticated-orcid":false,"given":"Simten","family":"Dagdas","sequence":"additional","affiliation":[{"name":"Ankara City Hospital,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2658-5978","authenticated-orcid":false,"given":"Gulsum","family":"Ozet","sequence":"additional","affiliation":[{"name":"Ankara City Hospital,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2021,3]]},"reference":[{"issue":"23","key":"ref1","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMra063728","article-title":"The myeloproliferative disorders","volume":"355","author":"Campbell PJ","year":"2006","journal-title":"N Engl J Med."},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12185-019-02812-w","article-title":"Progress in elucidation of molecular pathophysiology and its application in therapeutic decision-making for myeloproliferative neoplasms","volume":"111","author":"Takenaka K","year":"2020","journal-title":"Int J Hematol."},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ajh.22063","article-title":"The JAK2 exon 12 mutations: a comprehensive review","volume":"86","author":"Scott LM","year":"2011","journal-title":"Am J Hematol."},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/ajh.22058","article-title":"Infrequent occurrence of MPL exon 10 mutations in polycythemia vera and post-polycythemia vera myelofibrosis","volume":"86","author":"Pardanani A","year":"2011","journal-title":"Am J Hematol."},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2141.2010.08083.x","article-title":"Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis","volume":"149","author":"Boyd EM","year":"2010","journal-title":"Br J Haematol."},{"issue":"22","key":"ref6","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1182\/blood-2011-02-339002","article-title":"Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients","volume":"117","author":"Carobbio A","year":"2011","journal-title":"Blood."},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3324\/haematol.13346","article-title":"Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients","volume":"93","author":"Passamonti F","year":"2008","journal-title":"Haematologica."},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4274\/tjh.2015.0041","article-title":"Clinical features of 294 turkish patients with chronic myeloproliferative neoplasms","volume":"33","author":"Andi\u00e7 N","year":"2016","journal-title":"Turk J Haematol."},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood-2006-09-046342","article-title":"Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status","volume":"109","author":"Carobbio A","year":"2007","journal-title":"Blood."},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1182\/blood-2006-05-025544","article-title":"Management of extreme thrombocytosis in otherwise low-risk essential thrombocythemia; does number matter?","volume":"108","author":"Tefferi A","year":"2006","journal-title":"Blood."},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2007-04-083501","article-title":"Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel","volume":"110","author":"Tefferi A","year":"2007","journal-title":"Blood."},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3324\/haematol.2019.246207","article-title":"An agenda for future research projects in polycythemia vera and essential thrombocythemia","volume":"105","author":"Barbui T","year":"2020","journal-title":"Haematologica."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2147\/CLEP.S216787","article-title":"Vascular diseases in patients with chronic myeloproliferative neoplasms \u2013 impact of comorbidity","volume":"11","author":"Frederiksen H","year":"2019","journal-title":"Clin Epidemiol."},{"issue":"3","key":"ref14","first-page":"859","article-title":"JAK2-v617F mutation is associated with clinical and laboratory features of myeloproliferative neoplasms","volume":"36","author":"Duleti\u0107 AN","year":"2012","journal-title":"Coll Antropol."},{"issue":"16","key":"ref15","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1200\/JCO.2007.15.3569","article-title":"Leukocytosis and risk stratification assessment in essential thrombocythemia","volume":"26","author":"Carobbio A","year":"2008","journal-title":"J Clin Oncol."},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ejh.12064","article-title":"Leukocytosis in polycythemia vera and splenomegaly in essential thrombocythemia are independent risk factors for hemorrhage","volume":"90","author":"Chou YS","year":"2013","journal-title":"Eur J Haematol."},{"issue":"24","key":"ref17","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1002\/cncr.24664","article-title":"Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera","volume":"115","author":"Gangat N","year":"2009","journal-title":"Cancer."},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/leu.2008.177","article-title":"Evidence and expertise in the management of polycythemia vera and essential thrombocythemia","volume":"22","author":"Finazzi G","year":"2008","journal-title":"Leukemia."},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4274\/tjh.2016.0005","article-title":"Multicenter retrospective analysis of Turkish patients with chronic myeloproliferative neoplasmsmulticenter retrospective analysis of Turkish patients with chronic myeloproliferative neoplasms","volume":"34","author":"Soyer N","year":"2017","journal-title":"Turk J Haematol."},{"issue":"2","key":"ref20","first-page":"46","article-title":"Assessment of risk factors affecting thrombosis in patients with essential thrombocytosis","volume":"2","author":"Ko\u00e7ak MZ","year":"2018","journal-title":"J Surg Med."},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/bloodadvances.2019000211","article-title":"Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis","volume":"3","author":"Carobbio A","year":"2019","journal-title":"Blood Adv."},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/ejh.12806","article-title":"Anagrelide reduces thrombotic risk in essential thrombocythaemia vs. hydroxyurea plus aspirin","volume":"98","author":"Dombi P","year":"2017","journal-title":"Eur J Haematol."},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1590\/S1807-59322007000500004","article-title":"Effect of estrogen-progestin hormonal replacement therapy on blood coagulation and fibrinolysis in postmenopausal women","volume":"62","author":"Bonduki CE","year":"2007","journal-title":"Clinics (Sao Paulo)."},{"issue":"Suppl 2","key":"ref24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1590\/1806-9282.66.s2.22","article-title":"Risk of venous thromboembolism in users of contraception and menopausal hormone therapy during the COVID-19 pandemic","volume":"66","author":"Pires ALR","year":"2020","journal-title":"Rev Assoc Med Bras (1992)"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T12:18:45Z","timestamp":1630066725000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302021000400385&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["S0104-42302021000400385"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.20200778","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"type":"electronic","value":"1806-9282"},{"type":"print","value":"0104-4230"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}